array(25) {
["id"]=>
string(5) "79807"
["name"]=>
string(9) "羅東華"
["avatar"]=>
string(72) "https://img.39yst.com/uploads/19763/f64619ed2efffb53a0dea1a1445dc002.jpg"
["status"]=>
string(1) "0"
["rank_type"]=>
string(1) "2"
["duodian_main_id"]=>
string(1) "0"
["miaopai"]=>
string(0) ""
["graphic_consult"]=>
string(1) "0"
["position"]=>
string(15) "副主任醫(yī)師"
["introduction"]=>
string(9974) "一、基本情況:
專家門診時(shí)間:周二上午;周四下午
鼻咽鏡檢查時(shí)間:周四上午
工作語(yǔ)言:普通話,粵語(yǔ),客家話,英語(yǔ)
?
二、獲獎(jiǎng)及榮譽(yù)
2023年獲第三屆人民好醫(yī)生(鼻咽癌領(lǐng)域)優(yōu)秀典范專家;鼻咽科國(guó)家級(jí)青年文明號(hào)“優(yōu)秀號(hào)手”;多次被評(píng)為腫瘤防治中心“優(yōu)秀共產(chǎn)黨員”、“優(yōu)秀員工”;
?
三、教育經(jīng)歷:
2007/9-2010/6, 中山大學(xué), 腫瘤學(xué), 博士
2001/9-2003/6, 中山大學(xué), 腫瘤學(xué), 碩士
1996/9-2001/6, 中山醫(yī)科大學(xué), 臨床醫(yī)學(xué), 學(xué)士
?
四、工作經(jīng)歷:
2024/1-至今, 中山大學(xué), 腫瘤防治中心, 主任醫(yī)師
2016/1-2023/12, 中山大學(xué), 腫瘤防治中心, 副主任醫(yī)師
2011/1-2011/7, 美國(guó)Van Andel研究所,訪問(wèn)學(xué)者
2010/7-2010/12, 美國(guó)范德堡大學(xué)放療科, 訪問(wèn)學(xué)者
2006/1-2015/12, 中山大學(xué), 腫瘤防治中心, 主治醫(yī)師
2003/9-2005/12, 中山大學(xué), 腫瘤防治中心, 住院醫(yī)師
?
五、學(xué)術(shù)兼職:
中國(guó)抗癌協(xié)會(huì)腫瘤微環(huán)境專業(yè)委員會(huì)青年委員會(huì)委員
中國(guó)腫瘤放射治療聯(lián)盟第一屆放射免疫青年委員會(huì)委員
廣東省臨床醫(yī)學(xué)學(xué)會(huì)鼻咽癌精準(zhǔn)治療專業(yè)委員會(huì)常務(wù)委員?兼
鼻咽癌康復(fù)與營(yíng)養(yǎng)支持學(xué)組組長(zhǎng)
廣東省抗癌協(xié)會(huì)鼻咽癌專業(yè)委員會(huì)青年委員會(huì)常務(wù)委員
廣東省精準(zhǔn)醫(yī)學(xué)應(yīng)用學(xué)會(huì)頭頸腫瘤分會(huì)委員
廣東省醫(yī)院協(xié)會(huì)腫瘤防治管理分會(huì)腫瘤生物治療專業(yè)委員會(huì)常委
歐洲腫瘤內(nèi)科學(xué)會(huì)(ESMO)會(huì)員
中國(guó)臨床腫瘤協(xié)作委員會(huì)(CSCO)會(huì)員
中國(guó)抗癌協(xié)會(huì)(CACA)會(huì)員
?
六、主持或參加科研項(xiàng)目:
(1)國(guó)家自然科學(xué)基金青年項(xiàng)目,81402248,Snail/TELB/PAI-1通路在鼻咽癌轉(zhuǎn)移中的作用及臨床意義,2015/01-2017/12,23萬(wàn)元,已結(jié)題,主持
(2)廣東省省科技計(jì)劃項(xiàng)目,2012B031800364,uPAR/JAK1/STAT1信號(hào)通路促進(jìn)鼻咽癌細(xì)胞生長(zhǎng)、遷徙及轉(zhuǎn)移的分子機(jī)制及臨床意義,2013/01-2015/12,5萬(wàn)元,已結(jié)題,主持
(3)高?;究蒲袠I(yè)務(wù)費(fèi)5010臨床研究項(xiàng)目,5010-2016-08,TPF方案誘導(dǎo)化療聯(lián)合DDP同時(shí)期放化療及阿米福汀治療局部區(qū)域晚期兒童及青少年鼻咽癌的Ⅱ期前瞻性臨床試驗(yàn),2016/01-2017/12,10萬(wàn)元,已結(jié)題,主持
(4)國(guó)家自然科學(xué)基金重點(diǎn)項(xiàng)目,82230034, PALD1基因多態(tài)性調(diào)控血管內(nèi)皮損傷促進(jìn)放射性鼻咽壞死的作用及其機(jī)制研究,2023/01-2027/12,262萬(wàn)元,在研,排名第三
(5)廣東省省自然科學(xué)基金面上項(xiàng)目,2018A0303131004,AKR1C4對(duì)鼻咽癌獲得性放射抗拒的作用及其分子機(jī)制研究,2018/5-2021/4,10萬(wàn)元,結(jié)題,參加
(6)國(guó)家自然科學(xué)基金重點(diǎn)國(guó)際(地區(qū))合作研究項(xiàng)目,81520108022,EB病毒進(jìn)入鼻咽上皮細(xì)胞受體鑒定及感染機(jī)制,2016/01-2020/12,282萬(wàn)元,結(jié)題,參加
(7)國(guó)家自然科學(xué)基金委面上項(xiàng)目,81572912,鼻咽癌遠(yuǎn)處轉(zhuǎn)移分子標(biāo)志物的篩選及其預(yù)測(cè)模型的構(gòu)建,2016/01-2019/12,57萬(wàn)元,已結(jié)題,參加
(8)國(guó)家自然科學(xué)基金委面上項(xiàng)目,81572848,TBLR1誘導(dǎo)鼻咽癌轉(zhuǎn)移的分子機(jī)制,2016/01-2019/12,57萬(wàn)元,已結(jié)題,參加
(9)國(guó)家自然科學(xué)基金面上項(xiàng)目,81472386,腎癌細(xì)胞直接構(gòu)筑腫瘤微血管的分子機(jī)制及臨床意義,2015/01-2018/12,70萬(wàn)元,已結(jié)題,參加
(10)國(guó)家自然科學(xué)基金面上項(xiàng)目,81372442,髓系抑制性細(xì)胞(MDSC)參與鼻咽癌免疫耐受的作用和調(diào)控機(jī)制,2014/01-2017/12,75萬(wàn)元,已結(jié)題,參加
(11)國(guó)家自然科學(xué)基金面上項(xiàng)目,81272340,WNT5A 調(diào)控鼻咽癌轉(zhuǎn)移的細(xì)胞結(jié)構(gòu)、受體分析和信號(hào)通路,2013/01-2016/12,80萬(wàn)元,已結(jié)題,參加
(12)國(guó)家自然青年科學(xué)基金項(xiàng)目,81201629,IGFBP-6調(diào)控鼻咽癌轉(zhuǎn)移的分子機(jī)制,2013/01-2016/12,23萬(wàn)元,已結(jié)題,參加
(13)國(guó)家自然基金重點(diǎn)項(xiàng)目,30930045/C0703 ,Cdh1(FZR1)磷酸化新位點(diǎn)被調(diào)控的機(jī)理、對(duì)功能的影響及其意義,2010/01-2013/12,174萬(wàn)元,結(jié)題,參加
(14)廣東省科技計(jì)劃項(xiàng)目2012B031800255,AEG-1誘導(dǎo)鼻咽癌早期轉(zhuǎn)移的分子機(jī)制,2013/01-2016/12, 結(jié)題,參加
(15)廣東省自然科學(xué)基金自由申請(qǐng)項(xiàng)目,S2012010008379,HMGB1/RAGE通路介導(dǎo)的炎癥反應(yīng)在鼻咽癌骨轉(zhuǎn)移中的作用,2013/01-2016/12, 結(jié)題,參加
(16)參與多項(xiàng)鼻咽癌綜合治療的隨機(jī)對(duì)照臨床試驗(yàn)
?
七、代表性論著(部分):
(1) Xiao-Yun Li# , Dong-Hua Luo#(共同第一), Ling Guo# , Hao-Yuan Mo# , Rui Sun#, Shan-Shan Guo# , Li-Ting Liu#,et al,Qiu-Yan Chen*,Lin-Quan Tang*, Hai-Qiang Mai*;Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial;J Clin Oncol. 2022 Apr 10;40(11):1163-1173(IF:45.3)
(2) Dong-Hua Luo#, Xiao-Yun Li#,Shan-Shan Guo#,Wan-Ping Guo# ,Li-Ting Liu#,et al,Qiu-Yan Chen*,Lin-Quan Tang*,Hai Qiang Mai*.Paclitaxel liposome, cisplatin and 5-fluorouracil based induction chemotherapy followed by de-escalated intensity modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area:a phase II, single-arm trial.Lancet Reg Health West Pac.?2023 Aug 31:40:100895.
(3) Dong-Hua Luo#*, Jia-Xin Li#,Wan-Ping Guo#,Chen-Guang Guo,Xiao-Han Meng,Pei-Jun Xie,Jie-Yi Lin,Hao-Yuan Mo,Qun Zhang,Yong Chen*,Guo-Ping Shen*.The map of bone metastasis in nasopharyngeal carcinoma: A real-world study. Cancer Med.?2023 Sep;12(17):17660-17670
(4) Wan-Ru Zhang#, Yu-Yun Du, Chun-Yan Guo, Han Xing Zhou, Jie-Yi Lin, Xiao-Han Meng, Hao-Yuan Mo*, Dong-Hua Luo*; Prognostic Value of Serum Epstein Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.Cancer Res Treat.1598-2998.Original Article.2021 Oct;53(4):991-1003.
(5) Xue-Song Sun#, Si-Yi Xie#, Dong-Hua Luo#(共同第一), Li Ting Liu, Shan-Shan Guo , Sai-Lan Liu, Lin-Quan Tang , Qiu-Yan Chen*, Hai-Qiang Mai*.Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016. Radiother Oncol.?1879-0887.Original Article.2021 Sep;162:7-17.
(6) Yu-Yun Du#; Dong-Hua Luo#(共同第一); Xue-Song Sun#; Lin-Quan Tang;Hai-Qiang Mai; Qiu-Yan Chen; Jing-Hua Zhong; Dong-Mei Mai;Wan-Ru Zhang; Wen-Hui Chen*; Hao‐Yuan Mo*; Combining pretreatment plasma?Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic?stratification in patients with nasopharyngeal carcinoma: A cohort study, Cancer Med?2019 8(16),: 6841-6852.
(7) Ya Nan Jin; Wang Jian Zhang; Xiu Yu Cai; Mei Su Li; Wayne R Lawrence;?Si Yang Wang; Dong Mei Mai; Yu Yun Du; Dong Hua Luo*(共同通訊);?Hao Yuan Mo*; The?Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with?Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era, Cancer?Research and Treatment, 2018, 51(1): 34-42.
(8) Sang, Yi#; Chen, Ming-Yuan#; Luo, Donghua#(共同第一); Zhang, Ru-Hua; Wang, Li; Li,Mei; Luo, Rongzhen; Qian, Chao-Nan; Shao, Jian-Yong; Zeng, Yi-Xin; Kang,?Tiebang*; TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma., Oncotarget, 2015, 6(30): 29240-29253.
(9) Luo-Dong Hua#; Yang Jing#; Qiu Hui-Zhi; Shen Ting; Chen Qiu-Yan; Huang Pei-Yu; Sun Rui; Qian Chao-Nan; Mai Hai-Qiang; Guo Xiang; Mo Hao-Yuan*; A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging, BMC Cancer, 2014, 14(1): 0-653.
(10) Luo, Dong-Hua#; Chen, Qiu-Yan#; Liu, Huai; Xu, Li-Hua; Zhang, Hui-Zhong;Zhang, Lu; Tang, Lin-Quan; Mo, Hao-Yuan; Huang, Pei-Yu; Guo, Xiang; Mai,Hai-Qiang*; The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways, Journal of Translational Medicine, 2013, 11.
(11) Bao YN, Cao X, Luo?DH(共同第一),?Sun R, Peng LX, Wang L, Yan YP, Zheng LS, Xie P, Cao Y, Liang YY, Zheng FJ, Huang BJ, Xiang YQ, Lv X, Chen QY, Chen MY, Huang PY, Guo L, Mai HQ, Guo X, Zeng YX, Qian CN.Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle.?2014 Jun 15;13(12):1958-69.?
(12) Jiang R, Yang ZH,?Luo DH(共同第一),?Guo L, Sun R, Chen QY, Huang PY, Qiu F, Zou X, Cao KJ, Mai HQ, Guo X, Qian CN, Hong MH, Chen MY*. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol.?2014 Aug;31(8):80.
(13) Mo HY,?Luo DH(共同第一),?Qiu HZ, Liu H, Chen QY, Tang LQ, Zhong ZL, Huang PY, Zhao ZJ, Zhang CQ, Zhang Y, Mai HQ. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol). 2013 May; 25(5):308-17.
(14) 羅東華 曹京燕 紀(jì)紅 張華 曾木圣 洪明晃.鼻咽癌患者外周血全基因組芯片結(jié)果初步分析 中華腫瘤防治雜志 May 2011 Vol. 18 No.9 641-646
(15) 羅東華 洪明晃 肖錫賓. 鼻咽癌放療中唾液表皮生長(zhǎng)因子濃度與口腔粘膜炎的相關(guān)性分析 中華放射腫瘤學(xué)雜志 2008;Nov.,17(6)478-479
(16) 羅東華,洪明晃,郭靈 等.鼻咽癌放射性口腔粘膜炎多因素分析及建立判別模型的臨床價(jià)值 癌癥 2005; Jul.,24(7):850-854
(17) 羅東華,郭靈,洪明晃,張鋒.鼻咽癌顱骨腦膜轉(zhuǎn)移一例報(bào)告 中華腫瘤雜志 2005;27(1):62
(18) 羅東華,洪明晃.放射性口腔粘膜損傷的機(jī)制與防治.實(shí)用醫(yī)學(xué)雜志 2003;19(2):205~207
?
更新時(shí)間:2024.04.26"
["adept"]=>
string(96) "鼻咽癌個(gè)體化綜合治療,兒童青少年鼻咽癌診治,鼻咽癌遠(yuǎn)處轉(zhuǎn)移的防治"
["duodian_doctor_id"]=>
string(6) "115160"
["source_from"]=>
string(12) "醫(yī)院官網(wǎng)"
["is_jingxuan"]=>
string(1) "0"
["title_num"]=>
string(0) ""
["created"]=>
string(10) "1754967845"
["doctor_title"]=>
string(15) "副主任醫(yī)師"
["is_seniority"]=>
int(1)
["province_id"]=>
int(0)
["city_id"]=>
int(0)
["hospital_sort"]=>
string(2) "32"
["hospital"]=>
array(1) {
[0]=>
array(31) {
["id"]=>
string(5) "19763"
["name"]=>
string(30) "中山大學(xué)腫瘤防治中心"
["grade_id"]=>
string(1) "2"
["grade"]=>
string(0) ""
["type"]=>
string(1) "1"
["duodian_hospital_id"]=>
string(3) "814"
["address"]=>
string(27) "廣州市東風(fēng)東路651號(hào)"
["is_gongli"]=>
string(1) "1"
["logo"]=>
string(72) "http://pic.39yst.com/group2/M00/8B/F7/Co2PPWKfAdKACBy1AABiOqd-PC074.jpeg"
["is_pay"]=>
string(1) "0"
["pic"]=>
string(72) "http://pic.39yst.com/group2/M00/99/67/Co2PPWZ-H3qABl2PAAK_8SuU6HY43.jpeg"
["is_top100"]=>
string(1) "1"
["parent_areaid"]=>
string(2) "19"
["areaid"]=>
string(4) "1601"
["top100_sort"]=>
string(2) "32"
["guide"]=>
string(0) ""
["tel"]=>
string(38) "020-87673713,020-87765368 "
["is_seniority"]=>
string(1) "1"
["hospital_title"]=>
string(6) "三甲"
["hospital_grade_id"]=>
string(1) "2"
["hospital_type"]=>
string(12) "綜合醫(yī)院"
["hospital_type_id"]=>
string(1) "1"
["hospital"]=>
string(30) "中山大學(xué)腫瘤防治中心"
["department_id"]=>
string(2) "34"
["duodian_department_id"]=>
string(5) "11865"
["duodian_department_pid"]=>
string(5) "11850"
["department_name"]=>
string(9) "耳鼻喉"
["standard_department_id"]=>
string(2) "34"
["parent_standard_department_id"]=>
string(3) "103"
["hospital_department"]=>
string(9) "鼻咽科"
["duty"]=>
array(0) {
}
}
}
["version"]=>
int(40)
["isHaveSource"]=>
int(0)
["duty"]=>
string(0) ""
}